Impac Medical Systems to acquire Impath products
Impac Medical Systems has set in motion a proposal to purchase certain assets of Impath Inc. for $22 million.
The definitive agreement would have Impac acquire substantially all assets and certain liabilities of Tamtron Corp. and Medical Registry Services Inc., Impath's PowerPath pathology information management and cancer registry information system businesses.
Anticipating the addition of the PowerPath pathology information management system, Joseph K. Jachinowski, president and CEO of Mountain View, Calif.-based Impac, said that the company has "viewed this area as a synergistic adjacency to our core oncology management business. Seventy percent of all cases pathologists see are cancer-related and their analysis constitutes the first point in a long chain of cancer information management."
The definitive agreement would have Impac acquire substantially all assets and certain liabilities of Tamtron Corp. and Medical Registry Services Inc., Impath's PowerPath pathology information management and cancer registry information system businesses.
Anticipating the addition of the PowerPath pathology information management system, Joseph K. Jachinowski, president and CEO of Mountain View, Calif.-based Impac, said that the company has "viewed this area as a synergistic adjacency to our core oncology management business. Seventy percent of all cases pathologists see are cancer-related and their analysis constitutes the first point in a long chain of cancer information management."